Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Luminal A Breast Carcinoma”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Not applicableActive Not RecruitingNCT03165487
What this trial is testing

Comparison of the Breast Tumor Microenvironment

Who this might be right for
Triple Negative Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast
Columbia University 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT05982093
What this trial is testing

Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerHormone Receptor Positive Tumor+1 more
SOLTI Breast Cancer Research Group 48
Not applicableEnded earlyNCT03970967
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Who this might be right for
Breast CarcinomaMetastatic Breast CancerInvasive Breast Cancer+1 more
Alpha Tau Medical LTD. 1
Not applicableLooking for participantsNCT06891651
What this trial is testing

21-gene in Elder Breast Cancer Patients With Lymph Node Metastasis

Who this might be right for
Breast Cancer MetastaticBreast Cancer Survival
Qilu Hospital of Shandong University 35
Not applicableStudy completedNCT03715959
What this trial is testing

Nipple Aspirate Fluid in Detecting Breast Cancer

Who this might be right for
Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+25 more
Ohio State University Comprehensive Cancer Center 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT02592083
What this trial is testing

Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors

Who this might be right for
Early-Stage Breast CarcinomaHormone Receptor Positive Tumor
Thomas Hatschek 10
Large-scale testing (Phase 3)WithdrawnNCT06585969
What this trial is testing

A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerER-positive Breast CancerLuminal B+2 more
Danish Breast Cancer Cooperative Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT02238808
What this trial is testing

See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers

Who this might be right for
Estrogen Receptor Positive Breast Cancer
AHS Cancer Control Alberta 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT04759248
What this trial is testing

Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 55
Testing effectiveness (Phase 2)UnknownNCT05640778
What this trial is testing

Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)

Who this might be right for
Luminal B/HER2-negative Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University 30
Testing effectiveness (Phase 2)Study completedNCT05163106
What this trial is testing

Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole

Who this might be right for
Breast CancerHER2-negative Breast CancerER-positive Breast Cancer+3 more
University Hospital, Akershus 85
Not applicableStudy completedNCT05789771
What this trial is testing

Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia.

Who this might be right for
HR+/HER2- Breast CancerMetastatic DiseaseАdvanced Disease
Blokhin's Russian Cancer Research Center 136
Testing effectiveness (Phase 2)Active Not RecruitingNCT05392608
What this trial is testing

SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)

Who this might be right for
Neoplasm, BreastCongenital, Familial and Genetic Disorders
Borstkanker Onderzoek Groep 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134
What this trial is testing

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+19 more
Salubris Biotherapeutics Inc 263
Not applicableLooking for participantsNCT06590506
What this trial is testing

High Definition Medicine for Solid Tumors Oncology

Who this might be right for
Metastatic Solid TumorAdvanced Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III 300
Testing effectiveness (Phase 2)Study completedNCT03356860
What this trial is testing

Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.

Who this might be right for
Breast CancerTriple Negative Breast CancerLuminal B
Grand Hôpital de Charleroi 57
Large-scale testing (Phase 3)Study completedNCT01314833
What this trial is testing

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Who this might be right for
Primary Breast Cancer
Fudan University 1,570
Testing effectiveness (Phase 2)Study completedNCT03248427
What this trial is testing

Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 106
Large-scale testing (Phase 3)Study completedNCT03447132
What this trial is testing

Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant

Who this might be right for
Breast Neoplasm Female
International Cancer Research Group, United Arab Emirates 354
Testing effectiveness (Phase 2)UnknownNCT03712956
What this trial is testing

CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER

Who this might be right for
Breast Cancer
European Institute of Oncology 63
Load More Results